Erythromycin oxime, which is widely used and has broad market prospects, is the common intermediate of the second new generation erythromycin. The synthesis methods of erythromycin oxime were summarized as well as various methods were analyzed and compared. Aiming at the disadvantages of cumbersome process, low yields, too many solvents and etc. of synthesis of erythromycin oxime home and abroad, by changing the reaction conditions, selecting the appropriate free agent, optimizing stable reaction system pH, reducing the production of acidic degradation products during reaction process, improving the selective measures of isomers and other measures to find a green synthesis route of erythromycin oxime.
[ 1 ] Wiley P F，Gerzon，K, Flynn E. Erythromycin X structure of eryt-hromycin[ J ]. J Am Chem Soc，1957：6 062-6 070.
[ 2 ] Stephens V C，Conine. Esters of erythromycin. Ester of low molec-ular weight aliphatic acids[ J ]. Antibiotics Annual，1959：346-353.
[ 3 ] 邢其毅，徐瑞秋，周 政.基础有机化学（上册） [ M ].北京：人民教育出版社，1980：241-270.
[ 4 ] Djokic S, Tamburasov Z. Erythromycin oxime and 9-amino-3-o-clandinosyl-5-desosaminyl-611,12-trihdroy-246,8,10,12-hexam-ethyl-pentadecane-olide：US，347814[ P ]. 1969.
[ 5 ] Amano, Takehiro. Process for preparing erythromycin A oxime or as-alt therof：EP0342990A2 [ P ].1989.
[ 6 ] Chang S J.Process for preparing erythromycin A oxime： WO，97/38000 [ P ].1997.
[ 7 ] Djokic S, Kobrehel G, Lazarevski G.Erthromycin series.Part 11.Ring expansion of erythromycin A oxime by the Beckmann rearrangement [ J ]. Chem Soc Perkin Trans，1986：1 881-1 986.
[ 8 ] Djokic S,Kobrehel G,Lazarevski G.Erythromycin series 12..Antibac-terial in Vitro evaluation of 10-dihydro-10-deoxo-11-azaerythro-mycin A:Synthesis and structureactivity relationship of its acyl derivatives [ J ]. Antibiot, 1987，1 006-1 015.
[ 9 ] Yang B V,Goldsmith M. Novel product from Beckmann rearrange-ment of erythromycin A9（E ）-oxime[ J ].Tetrahedron Letters，1994，35（19 ）：3 025-3 028.
[10] Wilkening R R.Novel process for the preparation of 9-deoxxo-9( z )-hydroxyerythromycin A：EP，0503949 A1[ P ].1992.
[11] Wilkening R R. 9-Deoxo-9( z )-hyroxy-iminoerythromycin a and O-derivatives thereof：EP，0503932 A1[ P ].1992.
[12] Gasc J C, D’Ambrieres S G.New ether oxime derivatives of erythromycin A-A structure-activity relationsip study[ J ]. The Journal of Antibiotics,1991,44( 3 ):313-330.
[13] Yang B V.Inermediate for azithromycin：WO，94/26758[ P ].1994.
[14] Marti G, Antonio.New ether oxime derivatives of erythromycin A：AU，94/151[ P ].1994.
[15] 安达孝，森本繁夫，渡边庆昭.红霉素肟衍生物的制备方法：昭62-81399[ P ]. 1987-04-14.
[16] 森本繁夫，安达孝，朝贺俊文.红霉素肟衍生物的制备方法：昭62-87599[ P ].1987-04-22.
[17] Amano，Takehiro，Uraw-shi. Process for preparing erythromycin A oxime or a salt thereof：EP，0342990[ P ].1991.
[18] 林美娜，白景瑞，姚国伟.红霉素肟中杂质纯化及鉴定[ J ].辽宁化工，2003（2 ）.
[19] Robert R，Wilkening,Maplewood N J.Process for Preparation of 9-deoxo-9( Z )-hydroxyiino erythromycin A ：USP,5912331[ P ] .1999-06-15.
[20] Chang, Sou-Jen.Process for preparing erythromycin A oxime：WO, 97/38000[ P ] .1997-10-16.
[21] 石 岩，钱国华，梁建华.红霉素肟合成反应研究[ J ].合成化学，2001（2 ）.
[22] 邓志华，梁建华，孙京国.红霉素A肟的新合成方法[ J ].中国药物化学杂志，2003（2 ）.
[23] 王静宇，罗爱芹，邓玉林.红霉素肟的HPLC分析[ J ].北京理工大学学报，2002（6 ）.
[24] 马 敏，姚国伟，史 颖.阿奇霉素合成工艺的改进[ J ].精细化工，2006（8 ）.
[25] 叶 东，邓志华，梁建华.红霉素肟主杂质的分离和鉴定[ J ].北京理工大学学报，2002（2 ）.
[26] 林美娜，白景瑞，姚国伟.红霉素肟中杂质纯化及鉴定[ J ].辽宁化工，2003（ 2 ）.
[27] 王 博.阿奇霉素的合成工艺研究[ D ].河南郑州：郑州大学，2005.
[28] 楼科侠.红霉素A（E ）肟的合成及其贝克曼重排反应[ D ].天津：天津大学，2004.
